Your Source for Venture Capital and Private Equity Financings

Venture Capital News: ZeaVision Holdings Lands Investment

2014-10-08
ST. LOUIS, MO, Maker of the EyePromise brand of doctor-recommended nutraceuticals, has received an equity investment from DSM Venturing.
ZeaVision Holdings, Inc., maker of the EyePromise brand of doctor-recommended nutraceuticals, has received an equity investment from DSM Venturing, the corporate venture arm of Royal DSM, the global life sciences and material sciences company.


ZeaVision President, Chris Barber, commented: 'DSM has a long history of excellence and innovation in the nutrition industry. We are pleased to welcome DSM as a strategic investor which offers unique potential to strengthen ZeaVision's leadership position in the ocular nutrition market.'

Greg McParland, Senior Investment Manager of DSM Venturing says: 'This investment is at the core of our strategy to support emerging companies in our ecosystem and create new business opportunities. We commend ZeaVision for its innovative and science based approach to eye care and look forward to supporting the team in the expansion of their business.'

Will Black, Vice President of Marketing for DSM Nutritional Products says: 'DSM is excited to invest in the company. ZeaVision has made a significant contribution to expand research and scientific understanding of the role of nutrition in eye health.'

About ZeaVision Holdings, Inc.

ZeaVision, the maker of the EyePromise brand of eye health supplements, is passionate about preserving healthy vision through ocular nutrition and technology. With more than 20 years of research and innovation, ZeaVision pioneered the use of Zeaxanthin, a natural antioxidant and photo-protectant, for eye health. ZeaVision's science-based nutraceutical brands offer the highest levels of dietary Zeaxanthin available. ZeaVision understands the importance of the eye care professional's role in patient care and supports them and the patients they serve with leading nutritional brands and QuantifEye┬® MPS II the market leading macular pigment measurement instrument. With more than 40 million doctor-recommended doses consumed and counting, EyePromise products are made in the U.S.A. from the highest-quality, natural ingredients. Contact ZeaVision at 866.833.2800, support@eyepromise.com, or view additional information at www.eyepromise.com.

About DSM - Bright Science - Brighter LivingTM

Royal DSM is a global science-based company active in health, nutrition and materials. By connecting its unique competencies in Life Sciences and Material Sciences DSM is driving economic prosperity, environmental progress and social advances to create sustainable value for all stakeholders. DSM delivers innovative solutions that nourish, protect and improve performance in global markets such as food and dietary supplements, personal care, feed, pharmaceuticals, medical devices, automotive, paints, electrical and electronics, life protection, alternative energy and bio-based materials. DSM's 23,500 employees deliver annual net sales of about €9 billion. The company is listed on NYSE Euronext. More information can be found at www.dsm.com.

ZeaVision┬®, EyePromise┬®, QuantifEye┬®, and Eye-QTM are the respective logos and registered trademarks of ZeaVision Holdings Inc. All other trademarks herein are properties of their respective owners. All rights reserved.
(c)2011-2020 by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000 startups and 5,000 VC investors


Featured Reading